Susanne Heimerl

1.4k citations
27 papers · 1.1k indexed · h-index 16
Topics
Drug Transport and Resistance Mechanisms (9 papers)Cholesterol and Lipid Metabolism (8 papers)Platelet Disorders and Treatments (5 papers)

In The Last Decade

Susanne Heimerl

25 papers receiving 1.0k citations

Peers

Susanne Heimerl
Comparison fields: 5 of 94
  • Molecular Biology 576
  • Surgery 407
  • Oncology 324
  • Epidemiology 126
  • Cancer Research 122
Replace Ayce Yesilaltay with:
Ayce Yesilaltay United States
Alfred Boettcher Germany
Yi Bao China
Sally P.A. McCormick New Zealand
Jennifer Pattison United States
A Blouin Canada
Ryan Kopp United States
Karen M. Kassel United States
KM Yao Hong Kong
J P Le Couedic France
Susanne Heimerl relative to Ayce Yesilaltay United States Ayce Yesilaltay's profile →
Citations per field
00.5×1.5×1.9×
Ayce Yesilaltay · 1×
Citations per year

Countries citing papers authored by Susanne Heimerl

Since Specialization
Citations

This map shows the geographic impact of Susanne Heimerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Heimerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Heimerl more than expected).

Fields of papers citing papers by Susanne Heimerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Heimerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Heimerl. The network helps show where Susanne Heimerl may publish in the future.

Co-authorship network of co-authors of Susanne Heimerl

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Heimerl. A scholar is included among the top collaborators of Susanne Heimerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Heimerl. Susanne Heimerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 0
3 7
4 8
5 5
6 0
7 1
8 117
9 128
10 19
11 18
12 73
13 93
14 25
15 21
16 42
17 31
18 61
19 57
20 88

About Susanne Heimerl

Susanne Heimerl is a scholar working on Internal Medicine, Hematology and Oncology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Cholesterol and Lipid Metabolism (8 papers) and Platelet Disorders and Treatments (5 papers). The work is most often cited by research in Oncology (324 citations), Biochemistry (71 citations) and Surgery (407 citations). Susanne Heimerl has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Gerd Schmitz, Thomas Langmann, Gerhard Liebisch, Alexander Sigrüener, Wolfgang E. Kaminski, Christoph Moehle, Marcus E. Kleber, Winfried Maerz, Alfred Boettcher and Stefan Wallner. Their work appears in journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026